证券代码：601567 证券简称：三星医疗 公告编号：临 2025-067 宁波三星医疗电气股份有限公司 关于2025年半年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、利润分配预案内容 （一）利润分配预案的具体内容 截至2025年6月30日，宁波三星医疗电气股份有限公司（以下简称"公司"）母 公司期末未分配利润为人民币1,592,268,983.80元。经公司第六届董事会第二十五次会 议、第六届监事会第二十次会议审议通过，公司2025年半年度拟以实施权益分派股权 登记日登记的总股本（扣除回购专用账户的股份）为基数进行现金分红。本次利润分 配预案如下： 公司拟以本次实施权益分派股权登记日登记的总股本（扣除回购专用账户的股份） 为基数，向股东每10股派发现金红利（含税）4.85元。截至本公告披露日，公司总股 本为1,405,251,200股，扣除回购专用账户股份5,755,371股，公司可参与利润分配的总 股数为1,399,495,829股，以此计算预计合计派发现金红利约人民币678, ...

每经AI快讯，三星医疗（SH 601567，收盘价：24.66元）8月21日晚间发布公告称，公司第六届第二十 五次董事会会议于2025年8月21日在公司会议室以现场结合通讯方式召开。会议审议了《关于2025年半 年度报告及其摘要的议案》等文件。 2024年1至12月份，三星医疗的营业收入构成为：制造业占比76.16%，医疗业占比22.31%，其他业务占 比1.48%，金融业占比0.04%。 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 截至发稿，三星医疗市值为347亿元。 每经头条（nbdtoutiao）——最火游资不再是方新侠、章盟主、佛山无影脚？这名95后声名鹊起！ （记者 曾健辉） ...

Group 1 - Samsung Medical reported a revenue of approximately 7.972 billion yuan for the first half of 2025, representing a year-on-year increase of 13.93% [1] - The net profit attributable to shareholders of the listed company was approximately 1.23 billion yuan, showing a year-on-year increase of 6.93% [1] - Basic earnings per share were 0.87 yuan, reflecting a year-on-year increase of 7.41% [1] Group 2 - As of the report date, Samsung Medical's market capitalization stood at 34.7 billion yuan [2]

每经AI快讯，8月21日，三星医疗(601567.SH)发布2025年半年度报告，公司2025年上半年实现营业收入 79.72亿元，同比增长13.93%；实现归属于上市公司股东的净利润12.30亿元，同比增长6.93%。公司拟 向股东每10股派发现金红利4.85元（含税）。 ...

格隆汇8月21日丨三星医疗(601567.SH)公布半年度报告，报告期内，公司实现营业收入79.72亿元，同比 增长13.93%，实现归属于上市公司股东的净利润12.30亿元，同比增长6.93%，实现归属于上市公司股东 的扣除非经常性损益的净利润11.36亿元，同比增长5.34%。向股东每10股派发现金红利（含税）4.85 元。 ...

三星医疗公告，2025年上半年营业收入79.72亿元，同比增长13.93%。净利润12.3亿元，同比增长 6.93%。公司拟以本次实施权益分派股权登记日登记的总股本（扣除回购专用账户的股份）为基数，向 股东每10股派发现金红利（含税）4.85元。 ...

Group 1 - The core viewpoint of the articles highlights Samsung Medical's current stock performance, with a closing price of 25.19 yuan, an increase of 1.08%, and a rolling PE ratio of 14.84, marking a new low in 70 days, with a total market capitalization of 35.398 billion yuan [1][2] - The average PE ratio for the electric grid equipment industry is 39.42, with a median of 43.11, placing Samsung Medical at the 35th position within the industry [1] - As of March 31, 2025, Samsung Medical has 16,366 shareholders, a decrease of 898 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - For the first quarter of 2025, Samsung Medical reported an operating income of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33%, with a sales gross margin of 28.90% [2] - The PE (TTM) for Samsung Medical is 14.84, while the static PE is 15.67, and the price-to-book ratio is 2.81, with a total market value of 35.398 billion yuan [2] - Comparatively, the industry average PE (TTM) is 39.42, with a static PE of 42.97 and a price-to-book ratio of 3.97, indicating that Samsung Medical's valuation is significantly lower than the industry average [2]

Group 1 - The high-pressure oxygen chamber concept declined by 0.68%, ranking among the top declines in concept sectors as of the market close on August 20 [1] - Within the high-pressure oxygen chamber sector, companies such as Innovate Medical, Yinkang Life, and Aoyang Health experienced significant declines, while Iron Construction Heavy Industry, Samsung Medical, and Dahu Co. saw increases of 4.29%, 1.08%, and 0.89% respectively [1] - The high-pressure oxygen chamber sector experienced a net outflow of 444 million yuan in main funds, with Innovate Medical leading the outflow at 537 million yuan [2] Group 2 - The top gainers in the market included the Tonghuashun Fruit Index at 3.70%, AI mobile phones at 2.77%, and MCU chips at 2.60%, while the high-pressure oxygen chamber concept was among the top decliners [2] - The main funds saw significant outflows from several stocks in the high-pressure oxygen chamber sector, with Innovate Medical, Aoyang Health, and Dahu Co. being the most affected [2] - Conversely, Iron Construction Heavy Industry, Samsung Medical, and Jinling Pharmaceutical attracted net inflows of main funds, indicating a shift in investor interest [2]

Core Insights - Samsung Medical has 38 hospitals, including 32 rehabilitation hospitals, focusing on building a chain of rehabilitation hospitals with a specialty in critical rehabilitation [1] - The subsidiary Ningbo Mingzhou Hospital is a tertiary Class B general hospital with over 40 departments, including dentistry, ophthalmology, and medical aesthetics [1] - The company, headquartered in Ningbo, is part of the AUX Group and operates in manufacturing, medical services, and financial leasing [1] - In Q1 2025, the company achieved revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit attributable to shareholders of 489 million yuan, up 34.33% year-on-year [1]

Group 1 - The stock price of Samsung Medical (601567) closed at 24.21 yuan on August 15, 2025, with an increase of 1.81% and a turnover rate of 1.43% [1] - The trading volume was 201,600 shares, resulting in a total transaction amount of 484 million yuan [1] Group 2 - The company offers a range of charging pile products, including household and operational AC piles, integrated DC piles, and split intelligent group control systems, with power coverage from 7 kW to 640 kW [2] - The DC charging piles meet national, European, and American standards, excelling in safety protection, high power heat dissipation, and intelligent power distribution [2] - The medical segment of the company operates 38 hospitals, with 32 focused on rehabilitation, and includes departments such as dentistry, ophthalmology, and medical aesthetics at its Ningbo Mingzhou Hospital [2] Group 3 - On August 15, the net inflow of main funds into Samsung Medical was 24.56 million yuan, accounting for 5.07% of the total transaction amount [3] - Retail investors experienced a net outflow of 24.26 million yuan, representing 5.01% of the total transaction amount [3] - Speculative funds saw a net outflow of 296,900 yuan, which is 0.06% of the total transaction amount [3]